Gene mutation linked to developing Parkinson’s disease at a young age

Washington, Sept 18: Researchers have revealed that people with a specific gene mutation are more likely to develop Parkinson’s disease before they turn 50.

Study identifies genome’s role in rheumatoid arthritis

Washington, Sept 18: A new study has revealed that one specific part of the genome, TRAF1 (TNF receptor-associated factor 1), is associated with rheumatoid arthritis.

Rheumatoid arthritis is caused by an abnormal immune reaction to various tissues within the body. As well as affecting joints and causing an inflammatory arthritis, it can also affect many other organs of the body. An association has been shown previously in humans with the part of the genome that contains the human leukocyte antigens (HLAs), which are involved in the immune response.

New bone-growing nanomaterial may revolutionise orthopaedic implants

Washington, September 18: A team of engineers from Brown University has discovered a novel, bone-growing material that may revolutionise orthopaedic implants.

The study led by Associate Professor Thomas Webster shows that for orthopaedic implants to be successful, bone must meld to the metal that artificial hips, knees and shoulders are made of. He says that the new material may help increase this success rate.

ER episodes improve viewers’ health information

Washington, Sept 18: A new study has revealed that medical dramas on TV such as ‘ER’ are an influential medium for health communication.

Researchers at the University of Southern California found that the primetime NBC network drama had a positive influence on the attitudes and behaviours of viewers, particularly among men when it dealt with issues like teen obesity, hypertension and healthy eating habits.

Genes decide whether smoking-cessation drugs will help you kick the butt

Washington, Sept 18: According to a new study by the Centre for Addiction and Mental Health (CAMH), it is a person’s genes that decide whether or not a smoking-cessation drug would help when it comes to quitting smoking.

The study found that the enzyme, which is known to metabolise both the smoking cessation drug bupropion and nicotine, influences smoking cessation and is highly genetically variable in all ethnicities.

Benazir’s return to Pakistan will bring political stability: Kasuri

Lahore, Sep 18 (ANI): Pakistan’s Foreign Minister Khurshid Mehmood Kasuri has said that the return of former Prime Minister Benazir Bhutto to Pakistan would bring political stability to the country.

"We would welcome Bhutto on her return to the country," Kasuri told reporters on the sidelines of an exhibition organised at the French Embassy in Islamabad to celebrate the completion of 60 years of Pakistan-France friendship.

Kasuri said the government wanted to take along all parties for a national consensus on key issues.

Pages

News in Focus

UTI Asset Management Company (UTI AMC) Share Price Target at Rs 1,250: Motilal Oswal Research

Motilal Oswal has issued a BUY recommendation on UTI Asset Management Company (UTI AMC), projecting a 23% upside with a target price of Rs 1,250.

Royal Challengers Bengaluru vs Chennai Super Kings IPL 2025 Match Predictions and Odds for Bettors

The Royal Challengers Bengaluru (RCB) square off against Chennai Super Kings (CSK) in what could be the final on-field meeting between Indian cricket icons Virat Kohli and MS Dhoni.

Bajaj Finance Share Price Target at Rs 10,000: Motilal Oswal Research

In its latest research update, Motilal Oswal has maintained a Neutral stance on Bajaj Finance Ltd (BAF), assigning a target price of Rs 10,000—an upside of about 10% from the current market price o

Vedanta Share Price Target at Rs 525: Emkay Global Research

Emkay Global Financial Services has maintained its BUY call on Vedanta Limited, adjusting the target price downward to Rs 525 from Rs 550, reflecting a 25% potenti

Ambuja Cement Share Price Target at Rs 625: Choice Equity Broking

Ambuja Cement Limited has emerged as a frontrunner in India’s cement sector, bolstered by robust quarterly performance, margin expansion, and ambitious cost-reduction targets.